Combination Gemcitabine Plus S-1 Noninferior to Gemcitabine Plus Cisplatin for Advanced/Recurrent Biliary Tract Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combination Gemcitabine Plus S-1 Versus Gemcitabine Plus Cisplatin for Advanced/Recurrent Biliary Tract Cancer: The FUGA-BT (JCOG1113) Randomized Phase III Clinical Trial
Ann. Oncol 2019 Sep 30;[EPub Ahead of Print], C Morizane, T Okusaka, J Mizusawa, H Katayama, M Ueno, M Ikeda, M Ozaka, N Okano, K Sugimori, A Fukutomi, H Hara, N Mizuno, H Yanagimoto, K Wada, K Tobimatsu, K Yane, S Nakamori, H Yamaguchi, A Asagi, S Yukisawa, Y Kojima, K Kawabe, Y Kawamoto, R Sugimoto, T Iwai, K Nakamura, H Miyakawa, T Yamashita, A Hosokawa, T Ioka, N Kato, K Shioji, K Shimizu, T Nakagohri, K Kamata, H Ishii, J FuruseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.